Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESOMEPRAZOLE Cause Pain in extremity? 723 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 723 reports of Pain in extremity have been filed in association with ESOMEPRAZOLE (Esomeprazole Magnesium). This represents 1.0% of all adverse event reports for ESOMEPRAZOLE.

723
Reports of Pain in extremity with ESOMEPRAZOLE
1.0%
of all ESOMEPRAZOLE reports
19
Deaths
270
Hospitalizations

How Dangerous Is Pain in extremity From ESOMEPRAZOLE?

Of the 723 reports, 19 (2.6%) resulted in death, 270 (37.3%) required hospitalization, and 38 (5.3%) were considered life-threatening.

Is Pain in extremity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE. However, 723 reports have been filed with the FAERS database.

What Other Side Effects Does ESOMEPRAZOLE Cause?

Chronic kidney disease (35,281) Acute kidney injury (18,678) Renal failure (14,633) End stage renal disease (10,231) Renal injury (9,440) Gastrooesophageal reflux disease (4,746) Drug ineffective (4,420) Tubulointerstitial nephritis (4,024) Off label use (3,180) Pain (2,898)

What Other Drugs Cause Pain in extremity?

ADALIMUMAB (18,319) ETANERCEPT (14,837) METHOTREXATE (9,932) TOFACITINIB (8,675) SECUKINUMAB (6,700) TERIPARATIDE (6,012) TOCILIZUMAB (5,670) ABATACEPT (5,608) RITUXIMAB (5,080) PREGABALIN (5,023)

Which ESOMEPRAZOLE Alternatives Have Lower Pain in extremity Risk?

ESOMEPRAZOLE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE ESOMEPRAZOLE vs ESOMEPRAZOLE\NAPROXEN ESOMEPRAZOLE vs ESTAZOLAM ESOMEPRAZOLE vs ESTRADIOL ESOMEPRAZOLE vs ESTRADIOL CYPIONATE

Related Pages

ESOMEPRAZOLE Full Profile All Pain in extremity Reports All Drugs Causing Pain in extremity ESOMEPRAZOLE Demographics